1. Home
  2. CSBR vs NTIC Comparison

CSBR vs NTIC Comparison

Compare CSBR & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • NTIC
  • Stock Information
  • Founded
  • CSBR 1985
  • NTIC 1970
  • Country
  • CSBR United States
  • NTIC United States
  • Employees
  • CSBR N/A
  • NTIC N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • NTIC Industrial Specialties
  • Sector
  • CSBR Health Care
  • NTIC Industrials
  • Exchange
  • CSBR Nasdaq
  • NTIC Nasdaq
  • Market Cap
  • CSBR 90.2M
  • NTIC 74.9M
  • IPO Year
  • CSBR 1986
  • NTIC N/A
  • Fundamental
  • Price
  • CSBR $6.48
  • NTIC $7.42
  • Analyst Decision
  • CSBR Strong Buy
  • NTIC
  • Analyst Count
  • CSBR 1
  • NTIC 0
  • Target Price
  • CSBR $12.00
  • NTIC N/A
  • AVG Volume (30 Days)
  • CSBR 15.1K
  • NTIC 14.2K
  • Earning Date
  • CSBR 09-15-2025
  • NTIC 11-18-2025
  • Dividend Yield
  • CSBR N/A
  • NTIC 0.53%
  • EPS Growth
  • CSBR N/A
  • NTIC N/A
  • EPS
  • CSBR 0.21
  • NTIC 0.31
  • Revenue
  • CSBR $56,878,000.00
  • NTIC $85,268,129.00
  • Revenue This Year
  • CSBR $7.31
  • NTIC $1.09
  • Revenue Next Year
  • CSBR $12.01
  • NTIC $5.69
  • P/E Ratio
  • CSBR $30.18
  • NTIC $23.98
  • Revenue Growth
  • CSBR 10.11
  • NTIC 3.46
  • 52 Week Low
  • CSBR $3.75
  • NTIC $6.75
  • 52 Week High
  • CSBR $11.99
  • NTIC $15.09
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 47.59
  • NTIC 44.00
  • Support Level
  • CSBR $6.29
  • NTIC $7.62
  • Resistance Level
  • CSBR $6.79
  • NTIC $7.95
  • Average True Range (ATR)
  • CSBR 0.25
  • NTIC 0.28
  • MACD
  • CSBR 0.03
  • NTIC -0.04
  • Stochastic Oscillator
  • CSBR 33.83
  • NTIC 4.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

Share on Social Networks: